---
import BaseLayout from '../layouts/BaseLayout.astro';

const title = "ASPS Therapeutics Discovery Initiative - README";
const description = "Comprehensive overview of the ASPS Therapeutics Discovery Initiative, including scientific background, research data, roadmap, and methodology.";
---

<BaseLayout title={title} description={description}>
  <div class="max-w-4xl mx-auto px-6 py-12 text-gray-800 bg-white">
    <h1 class="text-4xl font-bold mb-8">ASPS Therapeutics Discovery Initiative — README</h1>
    
    <section id="science" class="mb-12">
      <h2 class="text-2xl font-bold mb-4">The Science</h2>
      <p class="mb-4">
        <strong>Alveolar Soft Part Sarcoma (ASPS)</strong> is a rare, translocation-associated sarcoma characterized by the specific <strong>ASPSCR1–TFE3</strong> gene fusion. This fusion protein acts as an aberrant transcription factor, driving the expression of genes that promote tumor growth and metastasis.
      </p>
      <p class="mb-4">
        <strong>Molecular Pathology:</strong> The ASPSCR1-TFE3 fusion results in the upregulation of the MET signaling pathway and angiogenesis-related genes.
      </p>
      <p class="mb-4">
        <strong>Vulnerabilities:</strong>
        <ul class="list-disc pl-6">
          <li><strong>Angiogenesis Dependence:</strong> ASPS is highly vascular, making it sensitive to VEGF pathway inhibitors.</li>
          <li><strong>Transcriptional Dependence:</strong> The tumor is addicted to the transcriptional program driven by the fusion protein.</li>
        </ul>
      </p>
    </section>

    <section id="research-data" class="mb-12">
      <h2 class="text-2xl font-bold mb-4">Research & Data</h2>
      <p class="mb-4">
        Our initiative focuses on generating and aggregating high-quality datasets to drive computational discovery.
      </p>
      <h3 class="text-xl font-semibold mb-2">Datasets</h3>
      <ul class="list-disc pl-6 mb-4">
        <li>Transcriptomic profiles of ASPS tumor samples.</li>
        <li>ChIP-seq data mapping TFE3 binding sites.</li>
        <li>Drug sensitivity screens.</li>
      </ul>
      <h3 class="text-xl font-semibold mb-2">Computational Outputs</h3>
      <p>
        We utilize advanced LLMs and machine learning models to analyze medical literature and genomic data to identify novel therapeutic targets.
      </p>
    </section>

    <section id="roadmap" class="mb-12">
      <h2 class="text-2xl font-bold mb-4">Roadmap</h2>
      <div class="space-y-4">
        <div>
          <h3 class="text-xl font-semibold">Phase 1: Data Aggregation & Infrastructure</h3>
          <p>Building the Sarcoma Raw Lake and Metadata store. Deploying the BioScraper and LLM analysis pipeline.</p>
        </div>
        <div>
          <h3 class="text-xl font-semibold">Phase 2: Target Identification</h3>
          <p>Using the Discovery Engine to identify high-confidence targets from literature and omics data.</p>
        </div>
        <div>
          <h3 class="text-xl font-semibold">Phase 3: Validation</h3>
          <p>Experimental validation of predicted targets in synthetic models.</p>
        </div>
      </div>
    </section>

    <section id="about" class="mb-12">
      <h2 class="text-2xl font-bold mb-4">About</h2>
      <p class="mb-4">
        <strong>Mission:</strong> To accelerate the discovery of effective therapeutics for ASPS through open science and computational innovation.
      </p>
      <p class="mb-4">
        <strong>Methodology:</strong> We combine automated literature analysis (BioScraper + LLM) with genomic data integration to build a comprehensive knowledge graph of ASPS biology.
      </p>
    </section>

    <section id="contact" class="mb-12">
      <h2 class="text-2xl font-bold mb-4">Contact</h2>
      <p>
        We welcome collaboration with researchers, clinicians, and data scientists.
      </p>
      <p>
        <strong>Collaboration Pathway:</strong> Please reach out via our GitHub repository or contact us directly to discuss data sharing and joint research opportunities.
      </p>
    </section>
  </div>

  <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "WebPage",
      "name": "ASPS Therapeutics Discovery Initiative README",
      "description": "Comprehensive scientific and research overview of Alveolar Soft Part Sarcoma (ASPS) initiative.",
      "mainEntity": {
        "@type": "MedicalCondition",
        "name": "Alveolar Soft Part Sarcoma",
        "alternateName": "ASPS",
        "associatedAnatomy": {
          "@type": "AnatomicalStructure",
          "name": "Soft tissue"
        },
        "possibleTreatment": [
          {
            "@type": "Drug",
            "name": "Atezolizumab"
          },
          {
            "@type": "Drug",
            "name": "Pazopanib"
          }
        ]
      }
    }
  </script>
  
  <script type="application/ld+json">
  {
    "page": "README",
    "disease": "Alveolar Soft Part Sarcoma",
    "driver": "ASPSCR1–TFE3 fusion",
    "mechanisms": ["angiogenesis dependency", "TFE3-driven transcription"],
    "therapeutic_vulnerabilities": ["VEGF pathway", "MET signaling"],
    "current_therapies": ["atezolizumab", "pazopanib"],
    "research_focus": ["target discovery", "computational modeling"]
  }
  </script>
</BaseLayout>
